SAMD9-related spectrum and myeloid neoplasm risk

A susceptibility or predisposition to MIRAGE syndrome and monosomy 7 myelodysplasia and leukemia syndrome 2, in which the cause of the disease is a mutation in the SAMD9 gene.

Also known as: MIRAGE syndrome susceptibility, SAMD9 form, SAMD9-related spectrum and myeloid neoplasm risk

33 clinical trials for this condition and its sub-types, 1 tagged with SAMD9-related spectrum and myeloid neoplasm risk itself.